Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Peroxisome proliferator-activated receptor-γ (PPAR-γ) activation confers functional neuroprotection in global ischemia.

Fatehi-Hassanabad Z, Tasker RA.

Neurotox Res. 2011 Apr;19(3):462-71. doi: 10.1007/s12640-010-9201-3. Epub 2010 Jun 4.

PMID:
20524105
2.

Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.

Luo Y, Yin W, Signore AP, Zhang F, Hong Z, Wang S, Graham SH, Chen J.

J Neurochem. 2006 Apr;97(2):435-48. Epub 2006 Mar 15.

3.

Neuroprotection by rosiglitazone in transient focal cerebral ischemia might not be mediated by glutamate transporter-1.

Verma R, Mishra V, Gupta K, Sasmal D, Raghubir R.

J Neurosci Res. 2011 Nov;89(11):1849-58. doi: 10.1002/jnr.22710. Epub 2011 Aug 8.

PMID:
21826699
4.

Neuroprotective effect of pioglitazone on acute phase changes induced by partial global cerebral ischemia in mice.

Medhi B, Aggarwal R, Chakrabarti A.

Indian J Exp Biol. 2010 Aug;48(8):793-9.

PMID:
21341537
5.

Activation of cerebral peroxisome proliferator-activated receptors γ (PPARγ) reduces neuronal damage in the substantia nigra after transient focal cerebral ischaemia in the rat.

Zuhayra M, Zhao Y, von Forstner C, Henze E, Gohlke P, Culman J, Lützen U.

Neuropathol Appl Neurobiol. 2011 Dec;37(7):738-52. doi: 10.1111/j.1365-2990.2011.01169.x.

PMID:
21366664
6.

The role of peroxisome proliferator-activated receptor γ, and effects of its agonist, rosiglitazone, on transient cerebral ischemic damage.

Lee CH, Park OK, Yoo KY, Byun K, Lee B, Choi JH, Hwang IK, Kim YM, Won MH.

J Neurol Sci. 2011 Jan 15;300(1-2):120-9. doi: 10.1016/j.jns.2010.09.005. Epub 2010 Sep 28.

PMID:
20880548
7.

Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factor-κB signaling pathway.

Zhang HL, Xu M, Wei C, Qin AP, Liu CF, Hong LZ, Zhao XY, Liu J, Qin ZH.

Neuroscience. 2011 Mar 10;176:381-95. doi: 10.1016/j.neuroscience.2010.12.029. Epub 2010 Dec 24.

PMID:
21185913
8.

Peroxisome proliferator-activated receptor-gamma-agonist, rosiglitazone, promotes angiogenesis after focal cerebral ischemia.

Chu K, Lee ST, Koo JS, Jung KH, Kim EH, Sinn DI, Kim JM, Ko SY, Kim SJ, Song EC, Kim M, Roh JK.

Brain Res. 2006 Jun 6;1093(1):208-18. Epub 2006 May 11.

PMID:
16696956
9.

Altered PPARgamma expression and activation after transient focal ischemia in rats.

Victor NA, Wanderi EW, Gamboa J, Zhao X, Aronowski J, Deininger K, Lust WD, Landreth GE, Sundararajan S.

Eur J Neurosci. 2006 Sep;24(6):1653-63.

PMID:
17004929
10.
12.

Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat.

Allahtavakoli M, Moloudi R, Arababadi MK, Shamsizadeh A, Javanmardi K.

Brain Res. 2009 May 19;1271:121-7. doi: 10.1016/j.brainres.2009.03.040. Epub 2009 Mar 28.

PMID:
19332033
13.

Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion.

Collino M, Aragno M, Mastrocola R, Gallicchio M, Rosa AC, Dianzani C, Danni O, Thiemermann C, Fantozzi R.

Eur J Pharmacol. 2006 Jan 13;530(1-2):70-80. Epub 2005 Dec 28.

PMID:
16386242
14.
15.

PPARgamma agonist pioglitazone reduces [corrected] neuronal cell damage after transient global cerebral ischemia through matrix metalloproteinase inhibition.

Lee KJ, Jang YH, Lee H, Yoo HS, Lee SR.

Eur J Neurosci. 2008 Jan;27(2):334-42. doi: 10.1111/j.1460-9568.2007.06007.x. Erratum in: Eur J Neurosci. 2008 May;27(9):2481.

PMID:
18215232
16.

Different effect of acute treatment with rosiglitazone on rat myocardial ischemia/reperfusion injury by administration method.

Abe M, Takiguchi Y, Ichimaru S, Kaji S, Tsuchiya K, Wada K.

Eur J Pharmacol. 2008 Jul 28;589(1-3):215-9. doi: 10.1016/j.ejphar.2008.05.005. Epub 2008 May 16.

PMID:
18571644
17.
18.

Rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, reduces infarction volume and neurological deficits in an embolic model of stroke.

Allahtavakoli M, Shabanzadeh AP, Sadr SS, Parviz M, Djahanguiri B.

Clin Exp Pharmacol Physiol. 2006 Nov;33(11):1052-8.

PMID:
17042914
19.

The intracerebral application of the PPARgamma-ligand pioglitazone confers neuroprotection against focal ischaemia in the rat brain.

Zhao Y, Patzer A, Gohlke P, Herdegen T, Culman J.

Eur J Neurosci. 2005 Jul;22(1):278-82.

PMID:
16029218
20.

Neuroprotective efficacy of the peroxisome proliferator-activated receptor-γ ligand in chronic cerebral hypoperfusion.

Sayan-Ozacmak H, Ozacmak VH, Barut F, Jakubowska-Dogru E.

Curr Neurovasc Res. 2011 Aug 1;8(3):190-9.

PMID:
21675957

Supplemental Content

Support Center